• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

Ethyl 4-bromopyrimidine-2-carboxylate (CAS No. 1379364-87-0): A Versatile Intermediate in Modern Pharmaceutical Synthesis

Ethyl 4-bromopyrimidine-2-carboxylate (CAS No. 1379364-87-0) is a significant compound in the realm of pharmaceutical chemistry, serving as a crucial intermediate in the synthesis of various biologically active molecules. Its unique structural features, combining a brominated pyrimidine core with an ester functional group, make it a valuable building block for medicinal chemists exploring novel therapeutic agents.

The compound's molecular structure, characterized by a pyrimidine ring substituted at the 4-position with a bromine atom and at the 2-position with a carboxylate ester, provides multiple reactive sites for further chemical modifications. This versatility is particularly advantageous in the development of small-molecule drugs, where precise structural manipulation can fine-tune pharmacological properties such as potency, selectivity, and metabolic stability.

In recent years, Ethyl 4-bromopyrimidine-2-carboxylate has garnered attention in the synthesis of antiviral and anticancer agents. The bromine atom at the 4-position serves as an excellent handle for cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are widely employed to construct complex heterocyclic frameworks. These reactions allow for the introduction of diverse aryl or heteroaryl groups, expanding the chemical space for drug discovery.

Moreover, the carboxylate ester moiety in Ethyl 4-bromopyrimidine-2-carboxylate can be readily transformed into other functional groups through hydrolysis, amidation, or transesterification. This reactivity enables the synthesis of a wide array of derivatives, including amides, carboxylic acids, and other esters, which are common pharmacophores in drug design. Such transformations are pivotal in optimizing lead compounds during the drug development pipeline.

Recent studies have highlighted the utility of Ethyl 4-bromopyrimidine-2-carboxylate in the synthesis of kinase inhibitors, which are critical targets in oncology research. The pyrimidine scaffold is a frequent motif in kinase inhibitors due to its ability to mimic ATP binding pockets. By incorporating this compound into drug candidates, researchers can develop molecules with enhanced binding affinity and selectivity against specific kinases involved in cancer pathways.

The compound's role extends beyond kinase inhibition; it has also been explored in the development of antiviral agents. Pyrimidine derivatives are known for their antiviral properties, particularly against viruses that rely on RNA-dependent RNA polymerases. Ethyl 4-bromopyrimidine-2-carboxylate can serve as a precursor for designing nucleoside analogs that interfere with viral replication by inhibiting key enzymatic steps.

In addition to its pharmaceutical applications, Ethyl 4-bromopyrimidine-2-carboxylate finds utility in agrochemical research. The structural motifs present in this compound are similar to those found in herbicides and fungicides, making it a valuable starting material for synthesizing novel crop protection agents. By leveraging its reactivity, chemists can develop environmentally friendly alternatives that offer effective pest control while minimizing ecological impact.

The synthesis of Ethyl 4-bromopyrimidine-2-carboxylate typically involves multi-step organic transformations starting from commercially available pyrimidine derivatives. The bromination at the 4-position is often achieved using brominating agents such as N-bromosuccinimide (NBS) or molecular bromine (Br?) under controlled conditions. Subsequent esterification of the carboxylic acid group yields the final product. These synthetic routes highlight the compound's accessibility and scalability for industrial applications.

Ongoing research continues to uncover new applications for Ethyl 4-bromopyrimidine-2-carboxylate, particularly in the field of medicinal chemistry. Advances in computational methods and high-throughput screening have accelerated the discovery of novel drug candidates derived from this intermediate. As our understanding of biological pathways grows, so does the demand for versatile building blocks like Ethyl 4-bromopyrimidine-2-carboxylate, which can be tailored to meet specific therapeutic needs.

The compound's compatibility with modern synthetic methodologies also underscores its importance in drug development pipelines. Techniques such as flow chemistry and microwave-assisted synthesis have been employed to streamline reactions involving Ethyl 4-bromopyrimidine-2-carboxylate, improving yields and reducing reaction times. These innovations underscore the compound's adaptability to evolving chemical technologies.

In conclusion, Ethyl 4-bromopyrimidine-2-carboxylate (CAS No. 1379364-87-0) is a multifaceted intermediate with broad applications in pharmaceuticals, agrochemicals, and material science. Its unique structural features and reactivity make it an indispensable tool for synthetic chemists seeking to develop innovative therapeutic agents. As research progresses, this compound will undoubtedly continue to play a pivotal role in advancing drug discovery and development efforts worldwide.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)